Open AccessAB051. P-19. A phase II study of infigratinib (BGJ398) in previously-treated advanced cholangiocarcinoma containing FGFR2 fusions
Author(s) -
Milind Javle,
Robin Kate Kelley,
Sameek Roychowdhury,
Karl Heinz Weiss,
Ghassan K. AbouAlfa,
Teresa Macarulla,
Saeed Sadeghi,
Dirk Waldschmidt,
Andrew X. Zhu,
Lipika Goyal,
Mitesh J. Borad,
Wei Peng Yong,
Ivan Borbath,
Anthony B. El-Khoueiry,
Philip Philip,
Susan Moran,
Yining Ye,
Mary Ising,
Nancy Lewis,
Tanios BekaiiSaab
Publication year - 2019
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.ab051
Subject(s) - medicine , clinical endpoint , gastroenterology , phases of clinical research , surgery , toxicity , clinical trial